Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Lockheed Martin has stopped the bleeding, closing at $510.12 after a 0.7% gain on Tuesday, but with Q3 earnings now 13 days away, the stock is still trading roughly 20% below the Street's mean price target of $637.85.
The analyst story is the most striking feature of the current setup. Rothschild & Co initiated coverage with a Buy and a $650 target on October 6, the freshest data point on a tape that has otherwise tilted constructively since July. UBS upgraded to Buy in early September, raising its target to $674, and Citigroup has ratcheted its target from $571 in July to $691 in August. That cluster of upward moves stands in contrast to a stock that has drifted 2.9% lower over the past month, leaving the gap between where the stock trades and where analysts think it should trade unusually wide. The dissenters are few: Morgan Stanley remains at Equal-Weight with a $690 target, RBC holds at Sector Perform with a $600 target, and TD Cowen trimmed its target to $560 in mid-July. Seven of the tracked analysts carry Buy ratings, and the consensus is Buy. The bull case centres on strong free cash flow, pension pre-funding, and the prospect of continued re-rating as the defence budget cycle builds; the bear case leans on the loss of the Next Generation Air Dominance programme and long-term uncertainty around the F-35.
Short positioning remains an afterthought. Short interest is just above 1% of the free float, a level that has barely moved in weeks and is down almost 12% over the past month. That is consistent with the picture from the previous note filed September 30: shorts have not been responsible for the slide, and they have not added as the stock fell. Borrow costs ticked up to 0.50% on the week, a 39% rise over seven days that sounds dramatic until you see the absolute level, half a percent is still among the cheapest borrows in the market. Availability is extraordinarily loose at roughly 7,900% of short interest, meaning the lending pool dwarfs the current short position many times over. Options positioning is similarly unconcerned: the put/call ratio has eased to 0.79, slightly below its 20-day average of 0.81 and well within normal range. There is no detectable hedging pressure building in the derivatives market ahead of the print.
Retail attention has picked up modestly. The Wikipedia views signal is running at a z-score of 1.45 against its own 90-day history, the highest reading in the current dataset window, suggesting the name is drawing more interest than usual. None of the alt data datasets here carry a measured lead against Lockheed's financials, so this is colour rather than signal, but the timing, two weeks from the earnings date, is consistent with a pre-results attention cycle.
Institutional ownership is stable and concentrated. State Street holds 14.3% of shares, BlackRock 8.2%, and the two Vanguard entities together account for roughly 9%. BlackRock added over a million shares in the most recent period, and Charles Schwab Investment Management added 654,000 shares. T. Rowe Price built a position of 1.37 million new shares as of September 1. The directional bias among the major holders is constructive, with no obvious trimming at scale from the top names. The 13D/G register carries only passive disclosures from Vanguard entities, no activist on the register.
Peer performance this week was mixed but broadly weak. RTX lost 2.0% on the week and NOC fell 4.3%, while LHX bucked the trend with a 0.6% gain. GD was roughly flat. Lockheed's own 0.4% weekly decline is comparatively mild within that group, but the sector backdrop remains soft, and the July 23 post-Q2 earnings jump of 13% has now been almost entirely retraced.
What to watch next is straightforward: the Q3 print on October 20 is the only event that matters now, and the size of the historical one-day move, 13% after Q2, means the market will be pricing for a wide range of outcomes in the days immediately ahead.
See the live data behind this article on ORTEX.
Open LMT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
